AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 13.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $27,000 | -99.7% | 44 | -99.6% | 0.00% | – |
| Q3 2019 | $10,064,000 | +19.7% | 11,917 | -4.6% | 0.00% | – |
| Q2 2019 | $8,407,000 | -62.3% | 12,488 | -54.0% | 0.00% | – |
| Q1 2019 | $22,288,000 | +1007.2% | 27,177 | +2060.3% | 0.00% | – |
| Q4 2018 | $2,013,000 | -81.7% | 1,258 | -62.1% | 0.00% | – |
| Q3 2018 | $10,999,000 | +45.9% | 3,323 | -0.4% | 0.00% | – |
| Q2 2018 | $7,537,000 | +370.2% | 3,335 | +280.7% | 0.00% | – |
| Q2 2014 | $1,603,000 | +75.4% | 876 | +17.9% | 0.00% | – |
| Q1 2014 | $914,000 | -59.3% | 743 | -39.1% | 0.00% | – |
| Q4 2013 | $2,245,000 | -92.8% | 1,220 | -91.9% | 0.00% | – |
| Q3 2013 | $31,141,000 | -35.1% | 15,117 | -21.2% | 0.00% | – |
| Q2 2013 | $47,958,000 | – | 19,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
| SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
| WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
| Caption Management, LLC | 748,200 | $503,000 | 0.02% |
| Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
| Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |